Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth R&D Pipeline Is 75% NMEs; Two Launches Per Year Will Start In 2006

Executive Summary

Three-quarters of the projects in Wyeth's research and development pipeline are new molecular entities, Wyeth Research President Robert Ruffolo, PhD, said during the company's R&D day in New York June 2
Advertisement

Related Content

Wyeth Shifting R&D Funds To Early-Stage Compound Research And Licensing
Wyeth Shifting R&D Funds To Early-Stage Compound Research And Licensing
Wyeth R&D Shifts Focus To New Products, Away From Lifecycle Management
Wyeth R&D Shifts Focus To New Products, Away From Lifecycle Management
Advertisement
UsernamePublicRestriction

Register

PS044136

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel